01 3Paladin Labs Inc.
02 6Purdue Pharma
03 1Valeant Canada LP
04 2Valeant Canada LP / Valeant Canada S.E.C.
01 62123160
02 32414349
03 32476201
01 12Tramadol Hydrochloride
01 2Controlled Release Tablet
02 3Extended-Release Tablet
03 4Tablet (Extended Release)
04 3Tablet (extended release)
01 62014-05-09
02 32021-06-26
03 32023-02-21
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Brand Name : RALIVIA
Patent Number : 2476201
Filing Date : 2003-02-21
Strength per Unit : 100 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Brand Name : RALIVIA
Patent Number : 2476201
Filing Date : 2003-02-21
Strength per Unit : 200 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Brand Name : RALIVIA
Patent Number : 2476201
Filing Date : 2003-02-21
Strength per Unit : 300 mg
Dosage Form : Tablet (extended release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-02-21
Date Granted : 2009-09-01
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Brand Name : TRIDURAL
Patent Number : 2414349
Filing Date : 2001-06-26
Strength per Unit : 100 mg
Dosage Form : Extended-Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Brand Name : TRIDURAL
Patent Number : 2414349
Filing Date : 2001-06-26
Strength per Unit : 200 mg
Dosage Form : Extended-Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Brand Name : TRIDURAL
Patent Number : 2414349
Filing Date : 2001-06-26
Strength per Unit : 300 mg
Dosage Form : Extended-Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-06-26
Date Granted : 2008-09-16
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Brand Name : ZYTRAM XL
Patent Number : 2123160
Filing Date : 1994-05-09
Strength per Unit : 150mg
Dosage Form : Tablet (Extended Release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Brand Name : ZYTRAM XL
Patent Number : 2123160
Filing Date : 1994-05-09
Strength per Unit : 200mg
Dosage Form : Tablet (Extended Release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Brand Name : ZYTRAM XL
Patent Number : 2123160
Filing Date : 1994-05-09
Strength per Unit : 300mg
Dosage Form : Tablet (Extended Release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
Brand Name : ZYTRAM XL
Patent Number : 2123160
Filing Date : 1994-05-09
Strength per Unit : 400mg
Dosage Form : Tablet (Extended Release)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-05-09
Date Granted : 2003-04-29
LOOKING FOR A SUPPLIER?
Market Place
